Incretin-Based Therapies: Revisiting Their Mode of Action
- PMID: 28575434
- PMCID: PMC5460946
- DOI: 10.1210/en.2017-00252
Incretin-Based Therapies: Revisiting Their Mode of Action
Figures
Comment on
-
Incretin Therapies Do Not Expand β-Cell Mass or Alter Pancreatic Histology in Young Male Mice.Endocrinology. 2017 Jun 1;158(6):1701-1714. doi: 10.1210/en.2017-00027. Endocrinology. 2017. PMID: 28323942 Free PMC article.
References
-
- Elrick H, Stimmler L, Hlad CJ Jr, Arai Y. Plasma insulin response to oral and intravenous glucose administration. J Clin Endocrinol Metab. 1964;24:1076–1082. - PubMed
-
- Nauck M, Stöckmann F, Ebert R, Creutzfeldt W. Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. Diabetologia. 1986;29(1):46–52. - PubMed
-
- Tahrani AA, Barnett AH, Bailey CJ. Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus. Nat Rev Endocrinol. 2016;12(10):566–592. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
